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Abstract
Purpose of review—To provide clinical investigators with an understanding of factors to consider
when wishing to add cytokine and inflammatory marker measurements to their studies.
Recent findings—Inflammation involves complex and coordinated responses of the immune
system to tissue damage. In the absence of tools to routinely assess inflammation within living tissues,
measurements of humoral factors such as cytokines and other inflammatory mediators or markers
can provide predictive clinical information plus insights into disease mechanisms. Historically,
enzyme-linked immunosorbent assays (ELISAs) became the gold standard, yet this approach of
measuring a single protein in each sample limits the amount of information which can be obtained
from limited amounts of human sample. In recent years, commercially available multiplex
technologies which detect large numbers of proteins in a limited volume have provided investigators
with opportunities to begin addressing the complexity of inflammatory responses. Nevertheless, great
attention needs to be paid to many aspects of study design, sample collection, sample measurement
and data analysis. These considerations are especially significant when using technologies for which
experience remains limited.
Summary—While measurements of peripheral levels of inflammatory markers can add important
mechanistic elements to human subject research, careful attention to conceptual and methodological
considerations is essential, especially when using novel technologies.
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Introduction
Inflammation involves a series of coordinated immune responses to tissue damage caused by
physical agents (e.g. trauma, surgery or radiation) or pathogens (e.g. bacteria or virus infection)
[1]. Cytokines are a diverse group of small secreted soluble proteins which permit
communication between immune cells with coordination of inflammatory responses [2].
Inflammation can be classified as either acute or chronic and characterized by tissue or organ
redness, pain, heat, swelling and loss of function because of increased local blood supply,
capillary permeability and migration of leukocytes out of venules in response to extracellular
stimulus [2]. Acute inflammation results from an initial immune response to harmful stimuli
resulting in increased movement of plasma, leukocytes, antibodies and complement from the
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blood into injured tissues [1]. When this process fails, evidence of inflammation remains.
During chronic inflammation neutrophils are replaced with macrophages and T cells may also
be present following infection [1;3]. As a result, destruction of tissue elements may contribute
to the development or progression of common autoimmune, cardiovascular and
neurodegenerative diseases [3]. In addition to such disease processes, a number of
epidemiologic studies of aging have linked elevations in circulating inflammatory markers to
the risk of dying, becoming disabled or being frail [4;5].
Recent developments involving highly sensitive Multiplex detection technologies have
presented clinical investigators with unprecedented opportunities to measure large numbers of
cytokines within a limited sample volume. However, as often happens with new technologies,
great initial enthusiasm was soon tempered with important concerns. First, clinical
investigators used to dealing with small numbers of commonly used inflammatory markers
(e.g. IL-6, TNF-α, CRP), have had to confront the remarkable complexity of designing and
analyzing inflammatory marker studies which may potentially include 100 or more different
cytokines or chemokines [2]. Second, since currently available Multiplex platforms and more
traditional ELISA-based systems exhibit distinct strengths and weaknesses, they should be
viewed as complementary tests, with the former being used more for discovery, while the latter
may play a confirmatory role [6]. Third, given the current state of Multiplex assays, such
measurements cannot simply be contracted out to commercial laboratories [6]. Fourth, none
of these discussions preclude the need to carefully consider factors involved in experimental
design, sample collection and sample preparation which may profoundly influence study
results[6].
The goal of this review is to help clinical investigators design experiments involving
inflammatory marker measurements. To that end, major cytokine classes involved in
coordination of the inflammatory response will be discussed, issues relevant to study design
will be considered, as will advantages and disadvantages of ELISA and Multiplex measurement
technologies.
Cytokines and Chemokines in the Inflammatory Response
Cytokines are large soluble proteins which act as immune regulators through interactions with
specific membrane receptors [2;7]. As soluble mediators of innate and adaptive immunity, they
are often involved in inflammation through their effects on antigen presentation, bone marrow
differentiation, cell recruitment, cell activation and adhesion molecule expression.
Source of cytokines and their roles in inflammation
Cytokines are made by many cells, yet inflammatory cytokines listed in Table 1 are mostly
produced by CD4+ T helper lymphocytes (Th) (T-lymphocytic derived) and macrophages
(mononuclear-phagocytic derived). Among these, type 1 helper (Th1) and type 2 helper (Th2)
were characterized by the secretion of distinct cytokines with a variety of functions [8]. Upon
encounter with antigen-presenting cells (APCs), naïve CD4+ T cells can differentiate into
either interferon-γ (IFN-γ) producing Th1 cells which interact with mononuclear phagocytes
destroying intracellular pathogens, or into IL-4 producing Th2 cells which interact with B cells
helping them to divide, differentiate and make antibody. Besides IFN-γ and IL-4, Th1 cells
also secrete TNF-β and IL-2, while Th2 cells secrete IL-5 and IL-13. While IL-10 was
previously classified as a Th2 cytokine, IL-10 is largely derived from regulatory T cells (Treg)
and has an anti-inflammatory property to downregulate inflammatory cytokine production
including TNF-α, IL-1 and IL-6[9]. Beyond their roles in clearing foreign antigens, abnormal
Th1 or Th2 responses may contribute to autoimmune diseases. IL-6 may play a role in the
development of T helper 17 (Th17) cells which are the preferential producers of IL-17A,
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IL-17F, IL-21, IL-26 and IL-22 [10;11]. IL-17A and IL-17F as a heterodimer signal activate
NF-κB driving inflammatory processes [10;11].
Monocytes are able to migrate from blood into tissues where they can differentiate into
inflammatory dendritic cells (DCs) or macrophages. DCs regulate the pathogen-specific
adaptive immune response and mediate the development of immunologic memory and
tolerance or during inflammation [12]. Macrophages remove apoptotic cells, produce growth
factors, and phagocytose based on their pathogen recognition receptors [3]. Monocytes,
macrophages and DCs release inflammatory cytokines and chemokines [3].
Anti-inflammatory cytokines include IL-4 and IL-10. IL-4 inhibits IFN-γ activation, while
IL-10 inhibits synthesis of IL-12, other pro-inflammatory cytokines and the Th17 cytokine
IL-17E. The effector function of all T helper cells is regulated by regulatory T cells (Tregs).
This T-cell subset defined by Foxp3 and CD25, has a crucial role in controlling allergic disease
such as asthma by secreting transforming-growth factor-β (TGF-β) and IL-10.
The roles of Chemokines and Chemokine receptors in inflammation
Chemokines are small chemotactic cytokines which are involved in neutrophil and monocyte
cell trafficking [13]. Most chemokines have ability to bind one or more G-protein-coupled
receptor (GPCR) to regulate a diversity of signal transduction pathways [13]. Chemokines have
only short half-lives and act on cells in close proximity to their release. As a result, few
chemokines are present at measurable level in the peripheral blood of most healthy individuals.
Even manu pro-inflammatory cytokines are only detectable in the peripheral circulation in
response to pathological changes. Nevertheless, the pattern of cytokines/chemokines released
or persisting at an inflammatory site may offer important insights into the pathogenesis of many
disease processes.
Sample Collection Issues
Reported levels of circulating cytokines can be impacted by sample collection protocols, such
as sample handling, processing and storage, and even patient behaviors prior to the collection.
Variables such as the time of day that the sample is obtained, the feeding state and acute stress
of the patient, the method of storage, duration of storage, and anticoagulant choice can influence
the reported levels of circulating cytokines. Standardized procedures for the collection of blood
samples and the storage of plasma prior to assay is recommended, so that inter-assay variations
are kept to a minimum and meaningful comparable data are produced. For plasma samples,
whole blood should be collected in sterile tubes with anticoagulants, placed on ice immediately,
and spun down as soon as possible, preferably within 30 minutes. Many cytokines have a short-
lived life and begin to degrade once drawn. Thus, small aliquots should be maintained, avoiding
repeated freeze-thawing.
Relationship to the time of day
Time of day that blood samples are collected should be synchronized, ideally to the morning
to attenuate the influence of circadian patterns and to allow for more meaningful comparisons.
Certain cytokines, particularly those that are impacted by glucocorticoids, exhibit distinct
diurnal variations which are highly predictable [14–16]. Lipopolysaccharide (LPS)-stimulated
whole blood, interferon gamma (IFN-gamma), tumour necrosis factor alpha (TNF-alpha),
interleukin 1 (IL-1) and IL-12 production exhibit distinct diurnal rhythms that peak in the early
morning [17] and are inversely related to the rhythm of plasma cortisol [17].
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Impact of fasting or food ingestion
Patients should be instructed to maintain normal dietary habits and to schedule blood sample
collection in the morning following an overnight fast. Feeding status can affect cytokine
production and action [18;19]. Chronic food intake patterns (ie. obesity or weight loss) have
been shown to affect circulating cytokine levels (TNF-α) [20]. Moreover, acute postprandial
measurements can be affected by feeding. For example, circulating C-reactive protein (CRP),
plasminogen activator inhibitor-1 (PAI-1) and IL-6 are elevated following a high-fat meal,
while TNF-alpha levels decrease [21;22]. This postprandial effect is likely modulated by the
insulin response to acute hyperglycemia [21;23]. Moreover the supplementation of particular
antioxidants such as glutathione, vitamins E and C can attenuate the feeding-induced rise in
plasma cytokines [23;24]. Hence patients should also be instructed to avoid such supplements
prior to testing.
Role of physical activity, exercise and stress
Patients should be instructed to maintain their normal levels of physical activity and to avoid
any unconventional strenuous activity prior to blood collection for cytokine measurements.
Physical stress, exercise, and trauma all can affect cytokine levels in circulation. While chronic
exercise training, improves fitness profiles and results in chronically decreased levels of many
circulating cytokines, acute exercise protocols result in short term changes in particular
cytokines. While, plasma cytokines are produced by many cell types, muscle cells are a major
source during exercise [25;26]. However, these particular responses are highly specific to the
exercise protocol and physiological strain (duration, nature, and intensity) [27;28]. For
instance, prolonged, endurance type exercise protocols result in acute increases (immediate to
2 h post-exercise) of IL-6, followed by IL-1ra and IL-10 [25;29].
Arterial-venous differences
Blood samples are typically obtained from venipuncture in routine medical care. Venous blood
sampling is less invasive than arterial sampling and provides samples after the blood has passed
through the tissues. Arterial blood sampling, on the other hand, is rare but occasionally used
in specialized procedures since it provides the circulating levels of cytokines prior to the
removal by the body tissues. Since cytokines are both removed and produced in local tissues,
arterial-venous differences in specific cytokine concentrations are important to consider when
comparing cytokine measures. There is also some evidence that local indwelling cannula
placement can affect the levels of cytokines (IL-6) as compared to a single needle stick [30].
Thus, artifacts in repeated measures are possible from the local production due to the indwelling
cannula rather than actual systemic changes in circulating cytokines.
Serum, plasma or whole blood?
Standard sampling procedures should be implemented when processing blood samples to
provide comparable and meaningful values. Cytokine measurement can be affected by the
anticoagulant used for the collection of blood and the preparation of biological sample obtained
from peripheral blood [31;32]. Serum and plasma are not equivalent. Serum preparation
involves the removal of fibrinogen, platelets, and other circulating proteins. This is relevant
since cellular elements during the process of coagulation can release inflammatory mediators
that may affect cytokine levels [19]. [33] For example, serum samples may contain IL-1 beta
secreted from blood leukocytes during the clotting process as compared to EDTA plasma
[33]. Peripheral blood collection in sterile EDTA (ethylenediamine tetraacetic acid)-treated
tubes has shown to produce the most consistent results for many cytokines [34;35]. Lithium
heparin and sodium citrate can decrease the measured levels of some cytokines (IL-6 and TNF-
α) as compared to serum or EDTA-plasma [35]. Additionally, lithium heparin in certain
Zhou et al. Page 4













collection tubes containing endotoxin can induce cytokine synthesis [32]. The presence of
EDTA can inhibit endotoxin-induced cytokine synthesis [32] and TNF synthesis in the tube
[36]. However, EDTA plasma is not recommended for bioassays, since EDTA is a chelating
agent. Instead, serum or low-level preservative-free heparin plasma is recommended for
bioassays[37;38].
Stability and storage considerations
The short half-life of cytokines, the production of cytokines by cells in peripheral blood
preparations, and the potential degradation make the stability, treatment, and storage of
biological samples important factors in circulating cytokine measurement, analysis and
interpretation [39]. Samples should be collected in sterile tubes, chilled, and processed quickly
to maintain cytokine stability [34]. Artifacts in cytokine measurements can be influenced by
the length of time plasma or serum is in contact with blood cells [37]. Cytokine production in
collected whole blood is apparent in as early as 2-hours following collection [32]. IL-6 levels
decrease in whole blood samples left at room temperature (significant after 4 h) [35].
Conversely, TNF-α levels increased, in similar conditions[35]. Thus, plasma or serum should
be separated from blood cells quickly to prevent degradation or absorption [38]. Samples
should be kept chilled until processing, since differences in cytokine measurements have been
observed between those kept at room temperature and −4°C [34]. Samples should be frozen at
−80°C until assayed and multiple freeze-thaw cycles should be avoided[38;40]. Most cytokines
are stable for up to 2 years of storage at −80°C [40]. However, degradation of IL-13, IL-15,
IL-17 and CXCL8 appear within one year of storage, whereas IL-2, IL-4, IL-12 and IL-18 are
stable for up to 3 years [40]. Other cytokines, such as IL-1α, IL-1β, IL-5, IL-6, and IL-10 are
degraded up to 50% within 2–3 years of storage[40]. After 4 years several cytokines are
degraded[40]. For long term storage of samples it may be ideal to use an internal control for
multiplex cytokine immunoassays [40]. Most of the cytokines are stable for up to three freeze
thaw cycles [34]. However, levels of certain cytokines like TNF-α increase with each
successive freeze–thaw cycle, becoming significant after three cycles [35]. Thus, multiple
freeze-thaw cycles should be avoided.
Sample preparation in community-based settings
When blood samples are collected in community-based settings, standard operating procedures
should be created, formalized, and adhered to. Standards should include detailed patient
instructions on preparing for the test, including diet and exercise restrictions, restricting time
of day, and sample handing. General guidelines might recommend:
• Blood collection should be done in the morning following an overnight fast
• Patients should be adequately hydrated prior to sampling.
○ It may be appropriate to measure urine specific gravity prior to blood
sampling. If hydration is low, patients should consume water until adequate
hydration is achieved.
• Physical activity patterns should be maintained in the days preceding the test and
uncustomary strenuous activity should be avoided
• Anticoagulants should be appropriately selected based on the desired assay and
standardized
• Biological samples should be chilled, quickly processed, and stored at the appropriate
temperature and duration to prevent artifacts in the measurement
• Blood samples should be handled appropriately.
Zhou et al. Page 5













○ When multiple blood tubes, containing varied anticoagulants are being
collected, care must be taken to order tubes appropriately to avoid
contamination.
○ Required tubes should be pre-chilled prior to collection
○ Blood tubes containing EDTA or heparin should be inverted appropriately
to allow the anticoagulant to dissolve
○ New pipette tips should be used for aliquoting each sample to prevent
contamination
ELISA
In the typical double antibody sandwich ELISA, antibody attached to the bottom of a well
provides both antigen capture and immune specificity, while another antibody linked to an
enzyme provides detection and an amplification factor. This approach enables accurate and
sensitive detection of the antigen, the cytokine of interest. As a result, ELISA has been
considered the standard cytokine measurement method and commercial ELISA kits are widely
used in clinical laboratories and biomedical research[41].
Nevertheless, ELISA performance is highly dependent on antibody quality, kit manufacturer,
as well as operator skill and experience [41;42]. In addition, ELISA permits the measurement
of only one cytokine at a time in a given sample aliquot, limiting the ability of investigators to
measure ever-growing numbers of inflammatory molecules. This concern becomes especially
acute when limited amounts of biological material are available. Difficulties also exist in
comparing two cytokine levels measured by two different ELISA assays, each under somewhat
different conditions.
Another limitation of ELISA-based assays is that the dynamic range (range over which there
is a linear relationship between the cytokine concentration and the absorbance reading) is
narrow relative to the range for other technologies such as multiplex assays. Thus, samples
with cytokine concentrations above the dynamic range have to be diluted for the assay. Dilution
not only reduces the concentration of the cytokine being measured, but may also diminish the
concentration of any circulating inhibitors or binding proteins. This is particularly relevant to
the use of serum samples, exaggerating differences between samples that have cytokine levels
within the dynamic range (do not require dilution in the assay) and samples above the dynamic
range (do require dilution).
MULTIPLEX ARRAYS
Multiplex arrays measure multiple cytokines in the same sample at the same time [6]. They
include flow cytometry, chemiluminescence, or electrochemiluminescence technology, with
flow cytometric (bead-based ) multiplex assays the most common [6]. Each bead set is coated
with a specific capture antibody, and fluorescence or streptavidin-labeled detection antibodies
bind to the specific cytokine-capture antibody complex on the bead set. Thus, multiple
cytokines in a biological liquid sample can be recognized and measured by the differences in
both bead sets, with chromogenic or fluorogenic emissions detected using flow cytometric
analysis. Commercially available bead-conjugated antibodies permit the measurement of up
to 25 different cytokines in the same sample. However, this number can be greatly expanded
if the investigator is willing to custom-conjugate antibodies of interest to one of nearly 100
different available beads.
The advantages of multiplex arrays when compared to ELISA include: a) high throughput
multiplex analysis; b) less sample volume needed, c) efficiency in terms of time and cost, d)
ability to evaluate the levels of one given inflammatory molecule in the context of multiple
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others; e) ability to perform repeated measures of the same cytokine panels in the same subjects
under the same experimental assay conditions; f) ability to reliably detect different proteins
across a broad dynamic range of concentrations.
Nevertheless, caution is necessary when considering the application of multiplex arrays in
clinical research. Experience with multiplex arrays remains limited. Although good
correlations between ELISA and multiplex have been reported [43;44], careful side-by-side
comparisons to other technologies are rare[45–47]. In addition, while concordance between
ELISA and multiplex is generally good when using tissue culture supernatant samples, it is
much less robust when using serum or plasma samples [48].
Also since multiplex assays involve potential interactions between multiple different
antibodies and cytokines (antigens) in the sample/assay solution, it cannot be assumed that a
reliable uniplex assay can just be simply added to a functioning multiplex assay. Non-reactivity
to all other antibodies must first be established and the lowest amount possible must be used
to minimize such cross-reactions. Problems can also arise from presence of a broad and varying
dynamic range with rare and abundant proteins being assayed together.
Abundant circulating proteins in serum or plasma samples, may also affect multiplex results
since all bead-based multiplex arrays reactions take place among molecules and antigens which
are freely mobile in solution. As a result, these multiplex arrays appear to be much more
sensitive than are ELISAs to altered levels of circulating proteins and inhibitors. As many such
abundant circulating proteins may change their levels during aging, inflammation or diseases,
this can obviously further complicate the picture.
Finally, as in the case of multiple comparison issues when conducting microarray data analysis,
multiplex data interpretation can be challenging, requiring careful knowledge of the molecular
pathways that lead to cytokine regulation, and careful attention to both study design and data
analysis. Moreover, such studies often require the evaluation of dynamic cytokine release by
well-characterized lymphocyte subpopulations[49;50].
Conclusion
While measurements of peripheral levels of inflammatory markers can add important
mechanistic elements to human subject research, careful attention to conceptual and
methodological considerations is essential, especially when using novel technologies. New
Multiplex technologies provide opportunities for moving beyond measurements of single
molecules to the evaluation of inflammatory pathways and networks. Nevertheless, in spite of
many advantages, these new technologies need to be used with caution, with results confirmed
using more traditional ELISAs. Furthermore, study design issues usch as the timing and manner
in which samples are collected and then processed from study subjects also need to be carefully
considered.
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Table 1





Induce fever, sickness behavior
Synthesis and release of acute phase proteins
IL-5 Th2
Mast cell
Eosinophil granulocyte proliferation, activation
and differentiation, B cell proliferation and secretion




Synthesis and release of acute phase proteins
Proliferation








Stimulate acute phase reaction
Cause leukocyte recruitment,
vascular leak, mediate septic shock
Induce apoptosis




Critical role on innate and adaptive immunity
against viral and bacterial infection
Stimulate macrophages, suppress Th2 cell activity
Th1 cell development
Promote NK cell activity, leukocyte migration
Tumor control
IL-17A Th17 cell Promote inflammatory response especially
allergic response
Mediate autoimmune diseases and
transplantation rejection






Th2 cell development and proliferation
Induce B cell class switching to IgE
Up-regulate MHC class II production
IL-10 Macrophage
Th2 cell
Inhibits Th1 pro-inflammatory cytokine sythesis






Block the activation of lymphocytes and monocyte
derived phagocytes, regulate proinflammatory
cytokines production
Suppress G1 cell cycle progression
Stimulate expansion of T reg cell
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